Table 7.
Overall survival, mean (95% CrI) | |||||
---|---|---|---|---|---|
Historical trials
|
|||||
FFCD-8801 | NSAS-GC | JCOG-9206-1 | JCOG-8801 | SWOG-7804 | |
Observed | 0.84 (0.62, 1.14) | 0.51 (0.29, 0.90) | 0.60 (0.31, 1.18) | 0.82 (0.54, 1.27) | 0.93 (0.70, 1.24) |
Meta-regression | 0.87 (0.63, 1.19) | 0.50 (0.25, 1.01) | 0.65 (0.32, 1.30) | 0.82 (0.53, 1.27) | 0.91 (0.67, 1.24) |
Meta-regression 2 | 0.86 (0.61, 1.23) | 0.50 (0.24, 1.03) | 0.64 (0.31, 1.31) | 0.82 (0.52, 1.30) | 0.91 (0.65, 1.28) |
Daniels & Hughes | 0.86 (0.55, 1.33) | 0.62 (0.30, 1.31) | 0.73 (0.32, 1.67) | 0.85 (0.48, 1.51) | 0.90 (0.60, 1.33) |
BRMA (Wishart) | 0.90 (0.45, 1.80) | 0.84 (0.32, 2.17) | 0.82 (0.31, 2.16) | 0.72 (0.30, 1.74) | 0.84 (0.39, 1.82) |
BRMA (PNF) | 0.87 (0.61, 1.25) | 0.87 (0.48, 1.57) | 0.87 (0.43, 1.72) | 0.88 (0.56, 1.38) | 0.86 (0.60, 1.21) |
EORTC-40813 | Tsavaris | ICCG-1/81 | ITMO | GITSG-8174 | |
| |||||
Observed | 0.85 (0.64, 1.14) | 0.55 (0.33, 0.89) | 0.85 (0.64, 1.13) | 0.98 (0.70, 1.37) | 0.74 (0.53, 1.04) |
Meta-regression | 0.78 (0.57, 1.06) | 0.58 (0.32, 1.03) | 0.91 (0.67, 1.24) | 0.93 (0.65, 1.33) | 0.76 (0.53, 1.09) |
Meta-regression 2 | 0.78 (0.56, 1.10) | 0.57 (0.31, 1.05) | 0.91 (0.65, 1.28) | 0.93 (0.64, 1.36) | 0.76 (0.52, 1.12) |
Daniels & Hughes | 0.79 (0.52, 1.19) | 0.67 (0.35, 1.32) | 0.91 (0.59, 1.40) | 0.92 (0.59, 1.44) | 0.78 (0.49, 1.25) |
BRMA (Wishart) | 0.81 (0.41, 1.63) | 0.81 (0.33, 1.97) | 0.88 (0.39, 1.97) | 0.87 (0.35, 2.16) | 0.83 (0.38, 1.80) |
BRMA (PNF) | 0.86 (0.62, 1.21) | 0.87 (0.51, 1.46) | 0.87 (0.62, 1.22) | 0.87 (0.61, 1.24) | 0.87 (0.60, 1.27) |
NCTTG-794151 | ECCOG-EST3275 | EORTC-40905 | ICCG | ||
| |||||
Observed | 1.02 (0.69, 1.51) | 0.94 (0.68, 1.30) | 0.93 (0.64, 1.37) | 1.05 (0.74, 1.49) | |
Meta-regression | 0.99 (0.65, 1.49) | 0.92 (0.66, 1.30) | 0.91 (0.62, 1.36) | 1.11 (0.74, 1.66) | |
Meta-regression 2 | 0.99 (0.64, 1.53) | 0.93 (0.64, 1.34) | 0.91 (0.60, 1.39) | 1.11 (0.72, 1.71) | |
Daniels & Hughes | 0.95 (0.55, 1.64) | 0.91 (0.57, 1.44) | 0.89 (0.53, 1.50) | 0.99 (0.62, 1.59) | |
BRMA (Wishart) | 0.87 (0.38, 2.02) | 0.80 (0.38, 1.70) | 0.92 (0.42, 2.01) | 0.89 (0.42, 1.92) | |
BRMA (PNF) | 0.86 (0.56, 1.32) | 0.86 (0.59, 1.24) | 0.87 (0.56, 1.33) | 0.86 (0.59, 1.25) | |
| |||||
Validation trials | |||||
A-cirera | B-CLASSIC | E-GOIM-9602 | F-GOIRC | ||
| |||||
Observed | 0.60 (0.39, 0.93) | 0.72 (0.52, 1.00) | 0.91 (0.69, 1.21) | 0.90 (0.64, 1.26) | |
Meta-regression | 0.57 (0.34, 0.94) | 0.58 (0.38, 0.88) | 0.92 (0.68, 1.23) | 0.96 (0.67, 1.37) | |
Meta-regression 2 | 0.57 (0.34, 0.96) | 0.58 (0.37, 0.89) | 0.92 (0.66, 1.27) | 0.96 (0.65, 1.40) | |
Daniels & Hughes | 0.62 (0.33, 1.16) | 0.62 (0.38, 1.02) | 0.90 (0.61, 1.32) | 0.93 (0.59, 1.48) | |
BRMA (Wishart) | 0.79 (0.32, 1.94) | 0.70 (0.32, 1.55) | 0.84 (0.41 1.73) | 0.80 (0.34, 1.84) | |
BRMA (PNF) | 0.86 (0.54, 1.36) | 0.80 (0.53, 1.20) | 0.87 (0.63, 1.20) | 0.87 (0.60, 1.26) |